GAZYVA (obinutuzumab) is a prescription medicine used with the chemotherapy drug, chlorambucil, to treat chronic lymphocytic leukemia (CLL) in adults who have not had previous CLL treatment.
treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL). treatment of CLL: In the presence of 17p
patients with progressive CLL require treatment, and this treatment results in an increased survival. A number of drugs that is currently used for CLL
by VA Morrison Cited by 6drug information for this topic. No drug references linked in this topic. chronic lymphocytic leukemia (CLL). Patients with CLL have
The CLL pipeline drugs market research report provides comprehensive information on the therapeutics under development for CLL
New Patient Appointments Radiation Therapy for CLL Stem Cell Transplant for CLL Investigational Approaches Immunotherapy New Therapeutic Drugs Ongoing
Rituxan is a drug that was approved for CLL almost 10 years ago. Ibrutinib has been around for a few years and was first approved for CLL treatment in 2024.
Four new drugs transform CLL treatment. Four new drugs transform CLL FDA approves two immunotherapies for melanoma. FDA approves two immunotherapies
by H Kajüter 2024 Cited by 19treatment of CLL. Until then therapy had been based on chemotherapy drugs. This study investigates whether survival in CLL patients improved
Comments
LWlurker